{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:49:31Z","timestamp":1766760571165,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["25877"],"award-info":[{"award-number":["25877"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00198-022-06313-1","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T17:39:32Z","timestamp":1643737172000},"page":"1501-1510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients\u2019 management using bisphosphonates therapy"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2480-0147","authenticated-orcid":false,"given":"Mohamed S.","family":"Abdel-Hamid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha M.","family":"Elhossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada A.","family":"Otaify","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif F.","family":"Abdel-Ghafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona S.","family":"Aglan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"5","key":"6313_CR1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1086\/497706","volume":"77","author":"M Ai","year":"2005","unstructured":"Ai M, Heeger S, Bartels CF, Osteoporosis-Pseudoglioma Collaborative Group et al (2005) Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet 77(5):741\u2013753. https:\/\/doi.org\/10.1086\/497706","journal-title":"Am J Hum Genet"},{"key":"6313_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1399-0004.1986.tb00823.x","volume":"29","author":"P Beighton","year":"1986","unstructured":"Beighton P (1986) Osteoporosis-pseudoglioma syndrome. Clin Genet 29:263. https:\/\/doi.org\/10.1111\/j.1399-0004.1986.tb00823.x","journal-title":"Clin Genet"},{"issue":"8","key":"6313_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/jmg.25.8.543","volume":"25","author":"H Somer","year":"1988","unstructured":"Somer H, Palotie A, Somer M et al (1988) Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies. J Med Genet 25(8):543\u2013549. https:\/\/doi.org\/10.1136\/jmg.25.8.543","journal-title":"J Med Genet"},{"key":"6313_CR4","first-page":"419","volume":"5","author":"D Lev","year":"2003","unstructured":"Lev D, Binson I, Foldes AJ et al (2003) Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome. Isr Med Assoc 5:419\u2013421","journal-title":"Isr Med Assoc"},{"issue":"1","key":"6313_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ajmg.a.33177","volume":"152A","author":"S Narumi","year":"2010","unstructured":"Narumi S, Numakura C, Shiihara T et al (2010) Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray. Am J Med Genet A 152A(1):133\u2013140. https:\/\/doi.org\/10.1002\/ajmg.a.33177","journal-title":"Am J Med Genet A"},{"key":"6313_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ejhg.2011.42","volume":"19","author":"CM Laine","year":"2011","unstructured":"Laine CM, Chung BD, Susic M et al (2011) Novel mutations affecting LRP5 splicing in patients with osteoporosispseudoglioma syndrome (OPPG). Eur J Hum Genet 19:875\u2013881. https:\/\/doi.org\/10.1038\/ejhg.2011.42","journal-title":"Eur J Hum Genet"},{"key":"6313_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00198-015-3245-4","volume":"27","author":"V Kheir","year":"2016","unstructured":"Kheir V, Munier FL, Aubry-Rozier B et al (2016) Potential blindness in children of patients with hereditary bone disease. Osteoporos Int 27:841\u2013844. https:\/\/doi.org\/10.1007\/s00198-015-3245-4","journal-title":"Osteoporos Int"},{"key":"6313_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/13816810.2015.1016240","volume":"36","author":"LG Welinder","year":"2015","unstructured":"Welinder LG, Robitaille JM, Rupps R et al (2015) Congenital bilateral retinal detachment in two siblings with osteoporosispseudoglioma syndrome. Ophthalmic Genet 36:276\u2013280. https:\/\/doi.org\/10.3109\/13816810.2015.1016240","journal-title":"Ophthalmic Genet"},{"issue":"4","key":"6313_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong Y, Slee RB, Fukai N et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107(4):513\u2013523. https:\/\/doi.org\/10.1016\/s0092-8674(01)00571-2","journal-title":"Cell"},{"key":"6313_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/s0092-8674(04)00216-8","volume":"116","author":"Q Xu","year":"2004","unstructured":"Xu Q, Wang Y, Dabdoub A et al (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a highaffinity ligand-receptor pair. Cell 116:883\u2013895. https:\/\/doi.org\/10.1016\/s0092-8674(04)00216-8","journal-title":"Cell"},{"key":"6313_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/humu.20191","volume":"26","author":"M Qin","year":"2005","unstructured":"Qin M, Hayashi H, Oshima K et al (2005) Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and\/or FZD4 genes. Hum Mutat 26:104\u2013112","journal-title":"Hum Mutat"},{"issue":"3","key":"6313_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00431-018-3299-3","volume":"178","author":"I Papadopoulos","year":"2019","unstructured":"Papadopoulos I, Bountouvi E, Attilakos A et al (2019) Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece. Eur J Pediatr 178(3):323\u2013329. https:\/\/doi.org\/10.1007\/s00431-018-3299-3","journal-title":"Eur J Pediatr"},{"issue":"5","key":"6313_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/13816810.2016.1253107","volume":"38","author":"P Maltese","year":"2017","unstructured":"Maltese P, Ziccardi L, Iarossi G et al (2017) Osteoporosis-pseudoglioma syndrome: report of two cases and a manifesting carrier. Ophthalmic Genet 38(5):473\u2013479. https:\/\/doi.org\/10.1080\/13816810.2016.1253107","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"6313_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11832-012-0385-3","volume":"6","author":"MS Aglan","year":"2012","unstructured":"Aglan MS, Hosny L, El-Houssini R et al (2012) A scoring system for the assessment of clinical severity in osteogenesis imperfecta. J Child Orthop 6(1):29\u201335. https:\/\/doi.org\/10.1007\/s11832-012-0385-3","journal-title":"J Child Orthop"},{"issue":"3","key":"6313_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jbspin.2004","volume":"72","author":"R Levasseur","year":"2005","unstructured":"Levasseur R, Lacombe D, de Vernejoul MC (2005) LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders. Joint Bone Spine 72(3):207\u2013214. https:\/\/doi.org\/10.1016\/j.jbspin.2004","journal-title":"Joint Bone Spine"},{"issue":"8","key":"6313_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2106\/00004623-199274080-00017","volume":"74","author":"CL McDowell","year":"1992","unstructured":"McDowell CL, Moore JD (1992) Multiple fractures in a child: the osteoporosis pseudoglioma syndrome. A case report. J Bone Joint Surg Am 74(8):1247\u20131249","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"6313_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000336193","volume":"77","author":"B T\u00fcys\u00fcz","year":"2012","unstructured":"T\u00fcys\u00fcz B, Bursal\u0131 A, Alp Z et al (2012) Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment. Horm Res Paediatr 77(2):115\u2013120. https:\/\/doi.org\/10.1159\/000336193","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"6313_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bone.2008.04.020","volume":"43","author":"EA Streeten","year":"2008","unstructured":"Streeten EA, McBride D, Puffenberger E et al (2008) Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates. Bone 43(3):584\u2013590. https:\/\/doi.org\/10.1016\/j.bone.2008.04.020","journal-title":"Bone"},{"issue":"1","key":"6313_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2012.10.003","volume":"24","author":"DM Joiner","year":"2013","unstructured":"Joiner DM, Ke J, Zhong Z et al (2013) LRP5 and LRP6 in development and disease. Trends Endocrinol Metab 24(1):31\u201339. https:\/\/doi.org\/10.1016\/j.tem.2012.10.003","journal-title":"Trends Endocrinol Metab"},{"key":"6313_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/35035117","volume":"407","author":"K Tamai","year":"2000","unstructured":"Tamai K, Semenov M, Kato Y et al (2000) LDL-receptorrelated proteins in Wnt signal transduction. Nature 407:530\u2013535. https:\/\/doi.org\/10.1038\/35035117","journal-title":"Nature"},{"key":"6313_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1083\/jcb.200201089","volume":"157","author":"M Kato","year":"2002","unstructured":"Kato M, Patel MS, Levasseur R et al (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303\u2013314. https:\/\/doi.org\/10.1083\/jcb.200201089","journal-title":"J Cell Biol"},{"issue":"4","key":"6313_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/humu.20916","volume":"30","author":"BD Chung","year":"2009","unstructured":"Chung BD, Kayserili H, Ai M et al (2009) A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats. Hum Mutat 30(4):641\u2013648. https:\/\/doi.org\/10.1002\/humu.20916","journal-title":"Hum Mutat"},{"issue":"12","key":"6313_CR23","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1002\/ajmg.a.38491","volume":"173","author":"M Pekkinen","year":"2017","unstructured":"Pekkinen M, Grigelioniene G, Akin L et al (2017) Novel mutations in the LRP5 gene in patients with Osteoporosis-pseudoglioma syndrome. Am J Med Genet A 173(12):3132\u20133135. https:\/\/doi.org\/10.1002\/ajmg.a.38491","journal-title":"Am J Med Genet A"},{"key":"6313_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2350-13-26","volume":"10","author":"J Korvala","year":"2012","unstructured":"Korvala J, J\u00fcppner H, M\u00e4kitie O et al (2012) Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med Genet 10:13\u201326. https:\/\/doi.org\/10.1186\/1471-2350-13-26","journal-title":"BMC Med Genet"},{"issue":"4","key":"6313_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1086\/383202","volume":"74","author":"C Toomes","year":"2004","unstructured":"Toomes C, Bottomley HM, Jackson RM et al (2004) Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J of Hum Genet 74(4):721\u2013730. https:\/\/doi.org\/10.1086\/383202","journal-title":"Am J of Hum Genet"},{"issue":"3","key":"6313_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejmg.2017.01.007","volume":"60","author":"SG Ergun","year":"2017","unstructured":"Ergun SG, Akay GG, Ergun MA, Per\u00e7in EF (2017) LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia. Eur J Med Genet 60(3):200\u2013204. https:\/\/doi.org\/10.1016\/j.ejmg.2017.01.007","journal-title":"Eur J Med Genet"},{"issue":"3","key":"6313_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1067\/mpd.2000.107838","volume":"137","author":"M Zacharin","year":"2000","unstructured":"Zacharin M, Cundy T (2000) Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates. J Pediatr 137(3):410\u2013415. https:\/\/doi.org\/10.1067\/mpd.2000.107838","journal-title":"J Pediatr"},{"key":"6313_CR28","unstructured":"Streeten E (2018). Trial of lithium carbonate for treatment of osteoporosis-pseudoglioma syndrome. ClinicalTrials.gov Identifier: NCT01108068"},{"issue":"1","key":"6313_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11926-004-0083-3","volume":"6","author":"C Deal","year":"2004","unstructured":"Deal C (2004) The use of intermittent human parathyroid hormone as a treatment for osteoporosis. Curr Rheumatol Rep 6(1):49\u201358. https:\/\/doi.org\/10.1007\/s11926-004-0083-3","journal-title":"Curr Rheumatol Rep"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06313-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06313-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06313-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T12:08:13Z","timestamp":1654862893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06313-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6313"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06313-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Research Ethical Committee of the National Research Centre (NRC), Cairo, Egypt, and conducted in accordance with the declaration of Helsinki ethical principles for medical research involving human subjects. An informed consent was obtained from the patients and or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}